创新生态系统序参量与演化关系——以我国医药制造业为例
|
摘要
正确认识产业创新生态系统演化机制有利于促进中国经济发展新常态的新兴战略顺利实施。在分析医药制造业创新生态系统内涵和特性的基础上运用哈肯模型构建了医药制造业创新生态系统演化模型和提出了研究假设,以《中国高技术产业统计年鉴》中医药制造业相关数据为基础进行实证分析。研究结果表明:创新人力投入强度是医药制造业创新生态系统的序参量,创新人力投入强度与技术创新能力之间存在显著协同关系;创新经费投入强度促进产品创新收益能力与技术创新能力,产品创新收益能力促进创新人力投入强度;而创新经费投入强度抑制创新人力投入强度,产品创新收益能力抑制技术创新能力。研究揭示了我国医药制造业创新生态系统的演化机制,为我国医药制造业的健康可持续发展提供了理论支撑和实践启示。
To understand accurately industrial innovation ecosystem evolution mechanism is conducive to promoting strategy of new normal of China's economic development. Through using Haken Model,this paper constructs a research model and hypothesis for pharmaceutical industry innovation ecosystem evolution mechanism. Based on the statistical data of China high-tech industry statistical yearbook,this paper makes an empirical analysis and gets three meaningful findings. Firstly,the human input intensity is the order parameter of pharmaceutical industry innovation ecosystem,and there is a synergic relationship between human input and technology innovation capacity. Secondly,the capital input intensity can promote product innovation capacity and technology innovation capacity,and the product innovation capacity can promote human input intensity. Thirdly,capital input intensity can restrain the human input intensity,and the product innovation capacity can restrain technology innovation capacity. The results of this study provide some practical enlightenment for healthy sustainable development of Chinese pharmaceutical industry.
To understand accurately industrial innovation ecosystem evolution mechanism is conducive to promoting strategy of new normal of China's economic development. Through using Haken Model,this paper constructs a research model and hypothesis for pharmaceutical industry innovation ecosystem evolution mechanism. Based on the statistical data of China high-tech industry statistical yearbook,this paper makes an empirical analysis and gets three meaningful findings. Firstly,the human input intensity is the order parameter of pharmaceutical industry innovation ecosystem,and there is a synergic relationship between human input and technology innovation capacity. Secondly,the capital input intensity can promote product innovation capacity and technology innovation capacity,and the product innovation capacity can promote human input intensity. Thirdly,capital input intensity can restrain the human input intensity,and the product innovation capacity can restrain technology innovation capacity. The results of this study provide some practical enlightenment for healthy sustainable development of Chinese pharmaceutical industry.
引文
[1]葛志远,刘奕汝.基于系统动力学的中国医药制造业可持续发展潜力研究[J].中国科技论坛,2016(2):54-59.
[2]智研咨询集团.2015-2022年中国医药制造业产业深度调研及投资前景分析报告[R],2015.11
[3]吴金希.创新生态体系的内涵、特征及其政策含义[J].科学学研究,2014,32(1):44-51.
[4]The European Commission.Open innovation 2.0(OI2)-sustainable economy&society-stability,jobs,prosperity[R].Dublin,Ireland,2013.
[5]JACKSON D J.What is an innovation ecosystem?[EB/OL].www.erc-assoc.org/docs/innovation_ecosystem.pdf,2012-11-28.
[6]曾国屏,苟尤钊,刘磊.从“创新系统”到“创新生态系统”[J].科学学研究,2013,31(1):4-12.
[7]MOOREJ F.The death of competition leadership and strategyin the age of business ecosystems[M].New York:Harper Business,1996.
[8]Council on Competitiveness.Innovate America:Thriving in a world of challenge and change[R].National Innovation Initiative Interim Report,2004.47
[9]吴绍波,顾新.战略性新兴产业创新生态系统协同创新的治理模式选择研究[J].研究与发展管理,2014,26(1):13-21.
[10]吕荣胜,叶鲁俊.中国节能产业创新生态系统耦合机理研究[J].科技进步与对策,2015(19):50-55.
[11]王霞,李雪,郭兵.基于SD模型的文化产业创新生态系统优化研究---以上海市为例[J].科技进步与对策,2014,31(24):64-70.
[12]谢子远.高技术产业区域集聚能提高研发效率吗?---基于医药制造业的实证检验[J].科学学研究,2015,33(2):215-224.
[13]孙峰,王有志,余景亮.我国医药制造业研发投入产出效率与对策---基于医药制造业PanalDate的实证研究[J].科技进步与对策,2014(22):46-50.
[14]何向武,周文泳,尤建新.产业创新生态系统的内涵、结构与功能[J].科技与经济,2015,28(4):31-35.
[15]李万,常静,王敏杰,等.创新3.0与创新生态系统[J].科学学研究,2014,32(12):1761-1770.
[16]朱永达,张涛,李炳军.区域产业系统的演化机制和优化控制[J].管理科学学报,2001,4(3):73-78.
[17]HAKEN H,FRASER A M.Information and self-organization:Amacroscopic approach to complex systems[J].American Journal of Physics,1989,57:958-959.
[18]李琳,刘莹.中国区域经济协同发展的驱动因素---基于哈肯模型的分阶段实证研究[J].地理研究,2014,33(9):1603-1616.
[19]王祥兵,张学立.货币政策传导系统协同演化机制研究---基于哈肯模型的理论与实证分析[J].管理评论,2014,26(11):57-66.
[20]郭莉,苏敬勤,徐大伟.基于哈肯模型的产业生态系统演化机制研究[J].中国软科学,2005(11):156-160.
[21]王祥兵,张学立.货币政策传导系统协同演化机制研究---基于哈肯模型的理论与实证分析[J].管理评论,2014,26(11):57-66.
[2]智研咨询集团.2015-2022年中国医药制造业产业深度调研及投资前景分析报告[R],2015.11
[3]吴金希.创新生态体系的内涵、特征及其政策含义[J].科学学研究,2014,32(1):44-51.
[4]The European Commission.Open innovation 2.0(OI2)-sustainable economy&society-stability,jobs,prosperity[R].Dublin,Ireland,2013.
[5]JACKSON D J.What is an innovation ecosystem?[EB/OL].www.erc-assoc.org/docs/innovation_ecosystem.pdf,2012-11-28.
[6]曾国屏,苟尤钊,刘磊.从“创新系统”到“创新生态系统”[J].科学学研究,2013,31(1):4-12.
[7]MOOREJ F.The death of competition leadership and strategyin the age of business ecosystems[M].New York:Harper Business,1996.
[8]Council on Competitiveness.Innovate America:Thriving in a world of challenge and change[R].National Innovation Initiative Interim Report,2004.47
[9]吴绍波,顾新.战略性新兴产业创新生态系统协同创新的治理模式选择研究[J].研究与发展管理,2014,26(1):13-21.
[10]吕荣胜,叶鲁俊.中国节能产业创新生态系统耦合机理研究[J].科技进步与对策,2015(19):50-55.
[11]王霞,李雪,郭兵.基于SD模型的文化产业创新生态系统优化研究---以上海市为例[J].科技进步与对策,2014,31(24):64-70.
[12]谢子远.高技术产业区域集聚能提高研发效率吗?---基于医药制造业的实证检验[J].科学学研究,2015,33(2):215-224.
[13]孙峰,王有志,余景亮.我国医药制造业研发投入产出效率与对策---基于医药制造业PanalDate的实证研究[J].科技进步与对策,2014(22):46-50.
[14]何向武,周文泳,尤建新.产业创新生态系统的内涵、结构与功能[J].科技与经济,2015,28(4):31-35.
[15]李万,常静,王敏杰,等.创新3.0与创新生态系统[J].科学学研究,2014,32(12):1761-1770.
[16]朱永达,张涛,李炳军.区域产业系统的演化机制和优化控制[J].管理科学学报,2001,4(3):73-78.
[17]HAKEN H,FRASER A M.Information and self-organization:Amacroscopic approach to complex systems[J].American Journal of Physics,1989,57:958-959.
[18]李琳,刘莹.中国区域经济协同发展的驱动因素---基于哈肯模型的分阶段实证研究[J].地理研究,2014,33(9):1603-1616.
[19]王祥兵,张学立.货币政策传导系统协同演化机制研究---基于哈肯模型的理论与实证分析[J].管理评论,2014,26(11):57-66.
[20]郭莉,苏敬勤,徐大伟.基于哈肯模型的产业生态系统演化机制研究[J].中国软科学,2005(11):156-160.
[21]王祥兵,张学立.货币政策传导系统协同演化机制研究---基于哈肯模型的理论与实证分析[J].管理评论,2014,26(11):57-66.